• Embed Doc
  • Copy Link
  • Readcast
  • Collections
  • CommentGo Back
 
Not long ago, I got the joy and despair of viewing many documents that wereinitially not to be seen, by order of the Department of Justice, yet found their way onvarious locations on the internet- specifically, the website:www.furiousseasons.com. The documents are, or were, in fact, evidence against EliLilly entirely representing their decade of deception promoting and over-medicatingothers with their drug called Zyprexa, which is in a class of medications calledatypical anti-psychotics. While a new a new molecular entity by definition, this newclass called atypical antipsychotics in fact is chemically similar to the older andtypical anti-psychotics that existed, such as Haldol, which were available over 50years ago. In many ways, the older antipsychotics are safer as well as being similarin efficacy compared with the atypicals such as Zyprexa. Perhaps this is why EliLilly did the things they did because they knew Zyprexa caused perhaps more harmthan good for those who took the medication. Of the several available atypical anti-psychotics now available, Zyprexa and Clozaril, which was the first atypical anti-psychotic, are believed to have the most toxic adverse events to those who takethese two in this class of medications.Launched in 1996, Eli Lilly did not appear to consider the evidence regarding theadverse effects that may occur to those who take this drug, yet it is believed thatthere was reason to state by Lilly that there should be caution regarding the use of Zyprexa in those patients prescribed this drug. With the belief that the maker of Zyprexa is and will be exonerated from any responsibility related to this drug, thepromotional campaign was implemented, and has continued ever since. Evidenceof this is a warning letter received by Lilly by the FDA as a warning due to the falseand misleading claims Lilly was making about Zyprexa less than 2 months after thisdrug was approved by the FDA.At the time Zyprexa was granted approval for marketing, the medication wasindicated only for schizophrenia and mania that exists in those with bipolar disorder.Schizophrenia has been defined as a disease that causes the sufferer to deviatefrom true reality, along with visual and auditory hallucinations. Bipolar disorder isanother mental disorder where the victim alternates from states of heightenedneurokinetics to periods of what can be brutal depression for the sufferer.Eli Lilly, known in recent years by many for their focus on marketing over science orresearch, greatly desired and hoped that Zyprexa would be a welcome blockbusterfor them, which is a medication that exceeds a billion dollars a year in sales as aminimum. And Eli Lilly appeared to have constructed the obedient and manipulatedsales force presumed to be a necessity for this monetary goal to occur withoutinterference. Yet in actuality, they created a sales force to break federal law from atleast the years of 1999 to 2003.
 
A note about pharmaceutical promotion: pharmaceutical representatives overallare attractive and young individuals with little if any medical knowledge or training,but are determined to have charming personalities along with a perception of obedience related to the pharmaceutical culture, and this is all Eli Lilly in particularwanted from the members of their sales force. The sales vocation is normallyassociated to contain members with a high affinity for money, it is believed, socorruptive acts such as off label promotion or overt kickbacks is not typically aconsideration of such people, overall, as history has shown. Therefore, if Eli Lilly’ssales representatives who happen to be instructed to sell Zyprexafor dementia ordepression, the orders will likely be followed by such promoters. Or if this sales forceis instructed to pay specifically targeted doctors large amounts of money for doinglittle or no work for this money given to such doctors, it still is not a problem for thesales force to maintain their obedience to their corporate God. This is theperception of not only myself, but many others as well. Plan of action meetings(POAs) are meetings that are held a few times a year by sizable pharmaceuticalcorporations to dispense orders to their sales representatives regarding thepromotion of their drugs.A few years after Eli Lilly launched Zyprexa, the maker appeared, according todocuments, anxious due to their obvious disappointment regarding the initialprediction that was speculated about the growth of this drug that was not meetingtheir expectations, so they had POA meetings throughout the nation and sharedwith the members of their sales force that there is fact a great benefit from amonetary paradigm of implementing ‘seeding trials’, as they are a mechanism forgenerating needed, although fabricated data void of any scientific gain of knowledge (this will be discussed later). This amazingly was done and implementedafterwards rather overtly. Even more unbelievable is that around this time, theZyprexasales force was instructed by Eli Lilly management to seek out clinical trialsites, along with investigators for these trials. Preferred by Eli Lilly was that theinvestigators had to either be Eli Lilly prescribing supporters or high volumeprescribers. This protocol described was written internally, along with the etiologyfor performing these sham clinical trials. Anything in writing can be golden, from anillegal situation such as this.In addition to the clinical trial plan of action of no scientific benefit identified, Eli Lillyinstructed its sales force to utilize what was in fact inaccurate promotional materialthat Eli Lilly gave its Zyprexasales representatives to be used on their sales callswithout exception. Even though this material was largely if not entirely false andmisleading, which was the intent of Eli Lilly, they encouraged their hired promotersthat such material was entirely accurate. To further saturate and corrupt theZyprexa sales force, they were coerced to blunt assertively what are at this timewidely recognized adverse effects of this medication, such as massive weight gain,along with glucose and lipid abnormalities- all of which are dangerous to the user of this medication.
 
 The corrosive promotion of Zyprexa by Eli Lilly continued as this dangerous medicalcorporation continued their efforts by intentionally altering certain Zyprexa articlesby essentially rewriting them, followed by being reviewed internally and notexternally by those who are called, 'regulators'. The purpose was to stimulate whatEli Lilly believed was clearly absent, which was much needed commercial interestrelated to Zyprexa. It unfortunately worked to a noticeable degree. This isaccording to what appear to be internal documents from Eli Lilly. Then it came time to essentially buy benign support groups, if not create what areessentially front groups, in hopes that this would improve the growth of Zyprexa.One example is that Eli Lilly paid the American Diabetes Association for theirassistance in obtaining endocrinologist consultants, which is a medical specialtythat treats, among other things, diabetes. To reduce any possibility of anunexpected contingency doing this, they went ahead and hired a good sized teamof diabetes educators. In 1999, Eli Lilly altered a Zyprexa report that originallyillustrated the glucose problem with the medication, and did so with deliberateintent and reckless disregard for others. Eventually, the American DiabetesAssociation became quite the critic of Eli Lilly because of their harmful behaviorregarding Zyprexa.A speculative thought regarding the freedom if not acceptance for this type of promotional behavior: there exists amazing alliances between Eli Lilly and the Bushadministration have existed as well. George H.W. Bush became an Eli Lilly directorafter leaving the CIA and lobbied to infect third world countries with Lillymedications. He also did his best to maximize tax breaks further for this industrythat now employs both himself and his political affiliation. In fact, many members of this administration have some connection with Eli Lilly. It seems to be a revolvingdoor issue once again. One could speculate that the Zyprexa campaign continuedfor so long because of the relationships the maker of the drug had and has withother powerful people. The next related psychotic tactic (pun somewhat intended) Eli Lilly created was anadvisory board paid well by this company to focus on the progressing concerns of Zyprexa. This tactic did work briefly, but did not change the view of the drug by themedical community in any way perceptually regarding their embellished drug.Understandably, the health care professionals in the medical community began toget vexed and irritated by Eli Lilly’s deceptive and overtly destructive promotionaltactics regarding Zyprexa- which included the company’s own speakers that wereutilized in the past expressing concerns overtly. Such events materializing resultedin many ways Eli Lilly being ostracized was because of their disregard for those theyare obligated to serve in the medical community, which are those in need of restoration of their health.Perhaps most disturbing and harmful was the Eli Lilly's intentional holding of crucialsafety information related to Zyprexa even before the drug was even approved. For
of 00

Leave a Comment

You must be to leave a comment.
Submit
Characters: ...
You must be to leave a comment.
Submit
Characters: ...